• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Par Drugs & Chemicals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 66408.0
  • ISIN : INE04LG01015
101.04 -1 (-0.95%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    100.40

  • Today’s High

    103.89

  • Open

    102.98

  • Perv Close

    102.01

  • 52W Low

    81.01

  • 52W High

    348.45

Key Indicators

  • P/E(TTM)

    9.30

  • Mar.Cap (₹Cr.)

    124.33

  • Div & Yield %

    0.00

  • Book Value(₹)

    80.44

  • Debt-Equity Ratio

    -0.95

  • AGM Date

    30-May-2025

  • EPS

    10.86

  • P/E Ratio

    9.30

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    124.33

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.30

  • BV (₹)

    80.40

  • Sales( ₹ in Cr.)

    100.97

  • NP (in Cr.)

    13.36

  • NP Var(%)

    -8.0

  • Div%

    0.0

  • CPS (₹)

    13.80

  • EPS (₹)

    10.90

  • Traded Value (₹ in Lakhs)

    124.33

  • 52 Week High

    348.45

  • 52 Week Low

    81.01

  • Price BSE

    0.0

  • Price NSE

    101.00

  • Market Capital( in Cr.)

    124.33

  • P/C Ratio

    7.30

  • P/E Ratio

    9.30

  • Price Vs.BV

    10.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 95.64 95.75 84.85 69.07 55.84 52.97
Excise Duty 0.00 0.00 9.78 8.32 0.00 6.64
Net Sales 95.64 95.75 75.07 60.75 55.84 46.33
Other Income 0.24 0.24 0.18 2.18 0.10 0.09
Stock Adjustments -0.47 0.70 0.79 0.21 -1.46 0.00
Total Income 95.41 96.69 76.04 63.14 54.48 46.42
EXPENDITURE :            
Raw Materials 33.32 41.03 29.61 22.09 22.19 19.22
Power and Fuel Cost 16.40 17.83 13.49 9.82 10.70 8.90
Employee Cost 5.50 4.89 4.10 3.98 4.11 3.64
Other Manufacturing Expenses 5.57 4.68 4.02 3.43 3.16 4.37
Selling and Administration Expenses 10.16 9.60 8.22 5.62 4.58 1.97
Miscellaneous Expenses 1.40 0.22 0.16 0.01 0.18 0.02
Employee Benefit Expenses 5.50 4.89 4.10 3.98 4.11 3.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 72.35 78.25 59.61 44.95 44.93 38.12
Operating Profit 23.06 18.44 16.43 18.19 9.54 8.29
Interest 0.11 0.13 0.45 0.64 0.79 1.96
Gross Profit 22.95 18.31 15.98 17.55 8.75 6.33
Depreciation 3.44 3.23 3.28 2.82 2.76 3.04
Profit Before Tax 19.51 15.08 12.70 14.73 5.99 3.29
Current Tax 4.98 3.80 3.35 3.36 1.00 0.68
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.04 -0.05 0.14 -0.25 0.23 0.10
Reported Net Profit 14.50 11.33 9.21 11.61 4.76 2.51
Extraordinary Items 0.01 0.11 0.00 1.53 0.02 0.00
Adjusted Net Profit 14.49 11.22 9.21 10.08 4.74 2.51
Adjustment below Net Profit -0.11 0.03 -0.01 -0.01 -0.01 -0.45
P & L Balance brought forward 48.16 36.80 29.13 17.53 14.48 12.41
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 1.54 0.00 1.70 0.00
P & L Balance carried down 62.55 48.16 36.80 29.13 17.53 14.48
Dividend 0.00 0.00 1.54 0.00 1.54 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 25.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 2.50 0.00
Earnings Per Share-Unit Curr 11.79 9.21 7.49 18.87 7.75 5.60
Earnings Per Share(Adj)-Unit Curr 11.79 9.21 7.49 9.44 3.88 -
Book Value 69.59 57.90 48.66 84.87 66.02 64.79
Book Value(Adj)-Unit Curr 69.59 57.90 48.66 42.44 33.01 -

Shareholding Pattern

  • Promoter Group

    73.37%

  • Public Share Holding

    26.63%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,027,750 73.37 9,027,750 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,027,750 73.37 9,027,750 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 175 0.00 175 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 175 0.00 175 2
2] Non Institution
Bodies Corporate 362,824 2.95 362,824 32
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 126,196 1.03 126,196 148
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 116,212 0.94 116,212 200
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 195,670 1.59 195,670 5
Individuals holding nominal share capital up to Rs. 1 lakh 2,302,048 18.71 2,302,048 15,073
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,276,711 26.63 3,276,711 15,464
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,304,636 100.00 12,304,636 15,472

Company Background

Par Drugs & Chemicals LtdPharmaceuticals - Indian - Bulk Drugs

  • Par Drugs & Chemicals Ltd
  • BSE Code : 66408.0
  • ISIN : INE04LG01015

  • Incorporation Year

    1999

  • Registered Office

    805 Dwarkesh Complex
    RC Dutt Road Alkapuri, Vadodara,
    Gujarat-390007

  • Telephone

    91-265-2332018

  • FAX

  • Chairman

    FALGUN VALLABHBHAI SAVANI

  • Managing Director

    FALGUN VALLABHBHAI SAVANI

  • Company Secretary

    Sanket Bhupendrabhai Trivedi

  • Auditor

    Sarupria Somani & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Par Drugs & Chemicals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Par Drugs & Che. 101.04 95.88 95.64 9.30 25.01
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92